Thomas Ebenhan

1.5k total citations
67 papers, 1.1k citations indexed

About

Thomas Ebenhan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Surgery. According to data from OpenAlex, Thomas Ebenhan has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Oncology and 18 papers in Surgery. Recurrent topics in Thomas Ebenhan's work include Radiopharmaceutical Chemistry and Applications (36 papers), Medical Imaging Techniques and Applications (24 papers) and Peptidase Inhibition and Analysis (18 papers). Thomas Ebenhan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (36 papers), Medical Imaging Techniques and Applications (24 papers) and Peptidase Inhibition and Analysis (18 papers). Thomas Ebenhan collaborates with scholars based in South Africa, Belgium and Netherlands. Thomas Ebenhan's co-authors include Mike Sathekge, Jan Rijn Zeevaart, Hendrik G. Kruger, Mariza Vorster, Olivier Gheysens, Thavendran Govender, Moshe Modiselle, Thabo Lengana, Christophe Van de Wiele and Alex Maes and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Thomas Ebenhan

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Ebenhan South Africa	18	549	336	309	239	225	67	1.1k
Laura Meléndez‐Alafort Italy	19	597 1.1×	232 0.7×	360 1.2×	205 0.9×	220 1.0×	75	1.2k
Donald J. Hnatowich United States	30	1.4k 2.5×	305 0.9×	386 1.2×	924 3.9×	271 1.2×	99	2.3k
Consuelo Arteaga de Murphy Mexico	20	543 1.0×	209 0.6×	281 0.9×	148 0.6×	212 0.9×	52	932
Filippo Galli Italy	18	288 0.5×	168 0.5×	321 1.0×	179 0.7×	360 1.6×	57	1.2k
Melissa Damschroder United States	23	882 1.6×	284 0.8×	452 1.5×	1.0k 4.2×	170 0.8×	42	2.3k
Lauren E. Colbert United States	17	109 0.2×	182 0.5×	319 1.0×	325 1.4×	140 0.6×	84	839
Martha Pedraza-López Mexico	17	435 0.8×	222 0.7×	188 0.6×	126 0.5×	136 0.6×	37	740
Syed Rizvi Australia	25	769 1.4×	354 1.1×	445 1.4×	656 2.7×	67 0.3×	56	2.1k
Koon Y. Pak United States	22	501 0.9×	93 0.3×	182 0.6×	594 2.5×	135 0.6×	77	1.3k
Judith M. Connett United States	24	858 1.6×	536 1.6×	590 1.9×	236 1.0×	304 1.4×	38	1.9k

Countries citing papers authored by Thomas Ebenhan

Since Specialization

Citations

This map shows the geographic impact of Thomas Ebenhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ebenhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ebenhan more than expected).

Fields of papers citing papers by Thomas Ebenhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ebenhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ebenhan. The network helps show where Thomas Ebenhan may publish in the future.

Co-authorship network of co-authors of Thomas Ebenhan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ebenhan. A scholar is included among the top collaborators of Thomas Ebenhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ebenhan. Thomas Ebenhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Summers, Beverley, et al.. (2024). Recently developed radiopharmaceuticals for bacterial infection imaging. EJNMMI Radiopharmacy and Chemistry. 9(1). 49–49. 4 indexed citations

2.

Summers, Beverley, et al.. (2024). Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies. Seminars in Nuclear Medicine. 54(6). 801–811. 1 indexed citations

3.

Sathekge, Mike, et al.. (2024). Visualisation of in vivo protein synthesis during mycobacterial infection through [68Ga]Ga-DOTA-puromycin µPET/MRI. Scientific Reports. 14(1). 19250–19250. 2 indexed citations

4.

Ebenhan, Thomas, et al.. (2023). Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy. Pharmaceuticals. 16(2). 227–227. 15 indexed citations

5.

Zeevaart, Jan Rijn, et al.. (2023). Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi8,Met(O2)11]-Substance P. International Journal of Molecular Sciences. 24(3). 2134–2134. 3 indexed citations

6.

Signore, Alberto, Alvaro A. Ordoñez, Gurpreet Kaur Aulakh, et al.. (2023). The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. Journal of Nuclear Medicine. 64(11). 1676–1682. 11 indexed citations

7.

Kruger, Hendrik G., Mike Sathekge, Jan Rijn Zeevaart, et al.. (2022). Using Antibiotics Scaffolds Will Warrant Novel Radiotracers for Effective Positron Emission Tomography Imaging of Infections: Triumph or Pitfall?. 36–36. 1 indexed citations

8.

Kruger, Hendrik G., Olivier Gheysens, Jan Rijn Zeevaart, et al.. (2022). Antibiotic‐Derived Radiotracers for Positron Emission Tomography: Nuclear or “Unclear” Infection Imaging?. Angewandte Chemie. 134(45).

9.

Kruger, Hendrik G., Olivier Gheysens, Jan Rijn Zeevaart, et al.. (2022). Antibiotic‐Derived Radiotracers for Positron Emission Tomography: Nuclear or “Unclear” Infection Imaging?. Angewandte Chemie International Edition. 61(45). e202204955–e202204955. 11 indexed citations

10.

Goethals, Ingeborg, et al.. (2022). Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma. Cancers. 14(7). 1821–1821. 4 indexed citations

11.

Bolcaen, Julie, et al.. (2021). Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals. 14(7). 626–626. 17 indexed citations

12.

Bolcaen, Julie, Jeroen Verhoeven, Ingeborg Goethals, et al.. (2021). A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma. Theranostics. 11(16). 7911–7947. 38 indexed citations

13.

Ebenhan, Thomas, et al.. (2020). In Vivo Albumin‐Binding of a C ‐Functionalized Cyclam Platform for ⁶⁴ Cu‐PET/CT Imaging in Breast Cancer Model. ChemMedChem. 16(5). 809–821. 4 indexed citations

14.

Lawal, Ismaheel O., Kgomotso Mokoala, Johncy Mahapane, et al.. (2020). A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 134–142. 23 indexed citations

15.

Ebenhan, Thomas, et al.. (2019). A toxicity profile of the Pheroid® technology in rodents. Toxicology Reports. 6. 940–950. 5 indexed citations

16.

Grobler, Anne, et al.. (2018). Radiopharmaceutical enhancement by drug delivery systems: A review. Journal of Controlled Release. 287. 177–193. 34 indexed citations

17.

Ebenhan, Thomas, Mike Sathekge, Thabo Lengana, et al.. (2017). ⁶⁸Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET/CT Imaging of Infections. Journal of Nuclear Medicine. 59(2). 334–339. 49 indexed citations

18.

Ebenhan, Thomas, R. Suhas, Thavendran Govender, et al.. (2015). Synthesis,⁶⁸Ga-Radiolabeling, and PreliminaryIn VivoAssessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent. BioMed Research International. 2015. 1–12. 23 indexed citations

19.

Lawal, Ismaheel O., et al.. (2015). Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT. Clinical Nuclear Medicine. 40(9). 755–756. 17 indexed citations

20.

Ebenhan, Thomas, Jan Rijn Zeevaart, Thavendran Govender, et al.. (2014). Preclinical Evaluation of ⁶⁸Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging. Journal of Nuclear Medicine. 55(2). 308–314. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact